Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Lisata Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Xenon Pharmaceuticals Inc. June 1, 202397.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 9, 2026 | Lisata Therapeutics Inc. | Grant or award | +30,456 | — | — |
| Jan 9, 2025 | Lisata Therapeutics Inc. | Grant or award | +15,789 | — | — |
| Jan 9, 2024 | Lisata Therapeutics Inc. | Grant or award | +19,480 | — | — |
| Dec 19, 2023 | Xenon Pharmaceuticals Inc. | Option exercise | +823 | $9.85 | $8,107 |
| Dec 19, 2023 | Xenon Pharmaceuticals Inc. | Option exercise | +3,497 | $9.85 | $34,445 |
| Jan 9, 2023 | Lisata Therapeutics Inc. | Grant or award | +20,000 | — | — |
Questions about Mohammad Azab
What boards is Mohammad Azab on?
Mohammad Azab sits on the boards of Lisata Therapeutics Inc. and Xenon Pharmaceuticals Inc.
How long has Mohammad Azab served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.